These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36622795)
1. TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling. Khan SF; Burmeister CA; Scott DJ; Sinkala M; Ramburan A; Wu HT; Schäfer G; Katz AA; Prince S Mol Cancer Res; 2023 Apr; 21(4):345-358. PubMed ID: 36622795 [TBL] [Abstract][Full Text] [Related]
2. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo. Hu D; Zhou J; Wang F; Shi H; Li Y; Li B Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system. Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665 [TBL] [Abstract][Full Text] [Related]
4. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection. Huang J; Yin C; Wang J J Obstet Gynaecol; 2023 Dec; 43(1):2161349. PubMed ID: 36645341 [TBL] [Abstract][Full Text] [Related]
5. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506 [TBL] [Abstract][Full Text] [Related]
6. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Munagala R; Aqil F; Jeyabalan J; Gupta RC Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343 [TBL] [Abstract][Full Text] [Related]
9. Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells. Trejo-Cerro O; Massimi P; Broniarczyk J; Myers M; Banks L J Virol; 2022 Oct; 96(20):e0122922. PubMed ID: 36197110 [TBL] [Abstract][Full Text] [Related]
10. AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression. Miller J; Dakic A; Spurgeon M; Saenz F; Kallakury B; Zhao B; Zhang J; Zhu J; Ma Q; Xu Y; Lambert P; Schlegel R; Riegel AT; Liu X J Med Virol; 2022 Aug; 94(8):3962-3977. PubMed ID: 35437795 [TBL] [Abstract][Full Text] [Related]
12. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells. Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. Bellone S; El-Sahwi K; Cocco E; Casagrande F; Cargnelutti M; Palmieri M; Bignotti E; Romani C; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD J Virol; 2009 Jul; 83(13):6779-89. PubMed ID: 19386711 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643 [TBL] [Abstract][Full Text] [Related]
15. [Correlation between high risk type human papillomavirus E6/E7 mRNA and cervical cancer]. Wang XH; Qian YM; Miao L; Le Y; Du J Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1003-5. PubMed ID: 27453113 [TBL] [Abstract][Full Text] [Related]
16. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer. Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421 [TBL] [Abstract][Full Text] [Related]
17. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
18. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells. Kahue CN; Jerrell RJ; Parekh A Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084 [TBL] [Abstract][Full Text] [Related]
19. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy. Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889 [TBL] [Abstract][Full Text] [Related]
20. RIPOR2 Expression Decreased by HPV-16 E6 and E7 Oncoproteins: An Opportunity in the Search for Prognostic Biomarkers in Cervical Cancer. Olmedo-Nieva L; Muñoz-Bello JO; Martínez-Ramírez I; Martínez-Gutiérrez AD; Ortiz-Pedraza Y; González-Espinosa C; Madrid-Marina V; Torres-Poveda K; Bahena-Roman M; Lizano M Cells; 2022 Dec; 11(23):. PubMed ID: 36497200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]